OPTIMISE CARE TO THE
ELDERLY WITH THE NEW 2016
AMH AGED CARE COMPANION
2016 Aged Care Companion Book Release.
This companion is a trusted, practical reference for doctors, nurses
and pharmacists who work with older people. It contains the latest
evidence-based information and is useful when conducting medication
reviews and other activities (eg case conferencing) aimed at improving
patient outcomes. There is also information on the management
of more than 70 conditions common in older people, including
dementia and its behavioural symptoms, delirium, cardiovascular
diseases, fall prevention, osteoporosis, COPD, insomnia, depression and
wound management. It also contains general principles on the use of
medicines in older people.
The May 2016 release contains new content including a topic on
actinic keratosis, information on the process of deprescribing, which is
important for optimising the use of medicines in older people, along
with a simple diagrammatic guide to inhaler devices with links to
instructions for use and considerations for choosing a suitable device
in older patients. Other topics reviewed include asthma, COPD, gout,
hypertension, dyslipidaemia and dyspepsia.
Online version also available.
For more information go to www.amh.net.au.
www.amh.net.au
IS THE INFORMATION YOU HAVE
ON DOSING FOR CHILDREN
RELEVANT & UP TO DATE?
July 2016 Children’s Dosing Companion
Print and Online Release
The AMH Children’s Dosing Companion is Australia’s national independent
dosing guide for prescribing and administering medicines to children
from birth to 18 years. The evidence-based and peer-reviewed content
provides detailed dosing information to assist health care practitioners
in hospital and community settings. Clearly written and concisely
laid-out, it now offers information for over 370 drugs.
The July 2016 Print and Online release has expanded its coverage on
doses for drugs used in hospital and in neonates. This update includes
a number of new monographs and other changes, some of those that
may be of interest include:
• new monographs for ezetimibe, mannitol, micafungin, propofol
and a range of antiretroviral drugs for HIV.
• a review of antifungal uses and doses, including amphotericin,
caspofungin, fluconazole, flucytosine and voriconazole.
• dosing regimens for vancomycin together with advice
regarding therapeutic drug monitoring.
• details regarding name changes to some drugs in Australia.
Online version also available. For more information go to www.amh.net.au.
www.amh.net.au